02/21/2024

Tempus Expanding Access to its Next-Generation Sequencing Tests as an In-Network Provider for Cigna

Tempus, a leader in artificial intelligence and precision medicine, today announced that the company has signed an agreement for in-network provider status with Cigna Healthcare. The collaboration signifies an important stride in enhancing accessibility to Tempus’ array of molecular profiling tests for Cigna’s extensive network, which comprises approximately 16 million members. 

At the core of Tempus’ offerings is a comprehensive molecular profiling portfolio that equips physicians with tailored solutions to help optimize treatment decisions throughout each patient’s clinical care journey. The inclusion of Tempus’ assays in Cigna’s in-network coverage is poised to facilitate broader access to precision oncology care. Notably, this may result in reduced out-of-pocket costs for patients undergoing such testing, aligning with the specifics of their individual plans.

“Comprehensive molecular profiling is a critical tool for physicians seeking to optimize their patients’ treatment plan, so we are thrilled to broaden access to this technology to Cigna’s many members across the country,” said Ezra Cohen, MD, Chief Medical Officer of Oncology at Tempus. 

About Tempus

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.

Related Content

View more
  • post image
    02/13/2025

    AI & ML in action: Real-time advances in precision medicine

    Explore the capabilities of the Tempus platform, where cutting-edge diagnostics meet actionable data insights to enhance precision medicine. Learn how AI and ML tools seamlessly integrate biomarkers into the diagnostic process, ensuring patients receive the right treatment(s) at the right time. Experience Tempus Lens in action, with an exclusive live demonstration of our newest AI advancements, and hear perspectives on AI's expanding role in healthcare and its transformative potential.

    Watch replay
  • post image
    01/27/2025

    Addressing health disparities at a large academic medical center: AI-driven cardiac care for aortic stenosis and mitral regurgitation

    Leveraging a natural language processing (NLP) based, artificial intelligence (AI) driven protocol, Tempus Next worked to help clinicians improve management of patients with severe aortic stenosis (sAS) and severe mitral regurgitation (sMR) by identifying patients who may have been previously overlooked.

    Read more
  • post image
    12/05/2024

    Advancing IO therapeutics: The convergence of novel biomarkers and combination strategies

    Explore the latest in immuno-oncology (IO), where emerging therapies are reshaping the landscape of cancer treatment. This webinar will focus on the role of novel biomarkers and combination treatment strategies in understanding and enhancing the immune system's response to cancer. Discover the significant developments that are helping to shape clinical trials and improving patient outcomes in IO and hear perspectives from industry experts on the potential of emerging therapies.

    Watch replay